163 related articles for article (PubMed ID: 38633426)
21. Analysis of five deep-sequenced trio-genomes of the Peninsular Malaysia Orang Asli and North Borneo populations.
Deng L; Lou H; Zhang X; Thiruvahindrapuram B; Lu D; Marshall CR; Liu C; Xie B; Xu W; Wong LP; Yew CW; Farhang A; Ong RT; Hoque MZ; Thuhairah AR; Jong B; Phipps ME; Scherer SW; Teo YY; Kumar SV; Hoh BP; Xu S
BMC Genomics; 2019 Nov; 20(1):842. PubMed ID: 31718558
[TBL] [Abstract][Full Text] [Related]
22. Identification of Heterozygous Single- and Multi-exon Deletions in IL7R by Whole Exome Sequencing.
Engelhardt KR; Xu Y; Grainger A; Germani Batacchi MG; Swan DJ; Willet JD; Abd Hamid IJ; Agyeman P; Barge D; Bibi S; Jenkins L; Flood TJ; Abinun M; Slatter MA; Gennery AR; Cant AJ; Santibanez Koref M; Gilmour K; Hambleton S
J Clin Immunol; 2017 Jan; 37(1):42-50. PubMed ID: 27807805
[TBL] [Abstract][Full Text] [Related]
23. Identification of copy number variants through whole-exome sequencing in autosomal recessive nonsyndromic hearing loss.
Bademci G; Diaz-Horta O; Guo S; Duman D; Van Booven D; Foster J; Cengiz FB; Blanton S; Tekin M
Genet Test Mol Biomarkers; 2014 Sep; 18(9):658-61. PubMed ID: 25062256
[TBL] [Abstract][Full Text] [Related]
24. Whole-genome sequencing of phenotypically distinct inflammatory breast cancers reveals similar genomic alterations to non-inflammatory breast cancers.
Li X; Kumar S; Harmanci A; Li S; Kitchen RR; Zhang Y; Wali VB; Reddy SM; Woodward WA; Reuben JM; Rozowsky J; Hatzis C; Ueno NT; Krishnamurthy S; Pusztai L; Gerstein M
Genome Med; 2021 Apr; 13(1):70. PubMed ID: 33902690
[TBL] [Abstract][Full Text] [Related]
25. Pioneering Informed Consent for Return of Research Results to Breast Cancer Patients Facing Barriers to Implementation of Genomic Medicine: The Kenyan BRCA1/2 Testing Experience Using Whole Exome Sequencing.
Torrorey-Sawe R; van der Merwe N; Mining SK; Kotze MJ
Front Genet; 2020; 11():170. PubMed ID: 32231682
[TBL] [Abstract][Full Text] [Related]
26. Germline copy number variations in BRCA1/2 negative families: Role in the molecular etiology of hereditary breast cancer in Tunisia.
Boujemaa M; Hamdi Y; Mejri N; Romdhane L; Ghedira K; Bouaziz H; El Benna H; Labidi S; Dallali H; Jaidane O; Ben Nasr S; Haddaoui A; Rahal K; Abdelhak S; Boussen H; Boubaker MS
PLoS One; 2021; 16(1):e0245362. PubMed ID: 33503040
[TBL] [Abstract][Full Text] [Related]
27. Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level.
Rangel-Pozzo A; Liu S; Wajnberg G; Wang X; Ouellette RJ; Hicks GG; Drachenberg D; Mai S
Cells; 2020 Aug; 9(8):. PubMed ID: 32784507
[TBL] [Abstract][Full Text] [Related]
28. Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families.
Van Marcke C; Helaers R; De Leener A; Merhi A; Schoonjans CA; Ambroise J; Galant C; Delrée P; Rothé F; Bar I; Khoury E; Brouillard P; Canon JL; Vuylsteke P; Machiels JP; Berlière M; Limaye N; Vikkula M; Duhoux FP
Breast Cancer Res; 2020 Apr; 22(1):36. PubMed ID: 32295625
[TBL] [Abstract][Full Text] [Related]
29. Targeted whole exome sequencing and Drosophila modelling to unveil the molecular basis of primary ovarian insufficiency.
Bestetti I; Barbieri C; Sironi A; Specchia V; Yatsenko SA; De Donno MD; Caslini C; Gentilini D; Crippa M; Larizza L; Marozzi A; Rajkovic A; Toniolo D; Bozzetti MP; Finelli P
Hum Reprod; 2021 Oct; 36(11):2975-2991. PubMed ID: 34480478
[TBL] [Abstract][Full Text] [Related]
30. Identification of New Copy Number Variation and the Evaluation of a CNV Detection Tool for NGS Panel Data in Polish Familial Hypercholesterolemia Patients.
Rutkowska L; Pinkier I; Sałacińska K; Kępczyński Ł; Salachna D; Lewek J; Banach M; Matusik P; Starostecka E; Lewiński A; Płoski R; Stawiński P; Gach A
Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011335
[TBL] [Abstract][Full Text] [Related]
31. Analytic validation of NeXT Dx™, a comprehensive genomic profiling assay.
Saldivar JS; Harris J; Ayash E; Hong M; Tandon P; Sinha S; Hebron PM; Houghton EE; Thorne K; Goodman LJ; Li C; Marfatia TR; Anderson J; Morra M; Lyle J; Bartha G; Chen R
Oncotarget; 2023 Aug; 14():789-806. PubMed ID: 37646774
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR study.
Cheng HF; Tsai YF; Liu CY; Hsu CY; Lien PJ; Lin YS; Chao TC; Lai JI; Feng CJ; Chen YJ; Chen BF; Chiu JH; Tseng LM; Huang CC
Breast Cancer Res; 2023 Dec; 25(1):152. PubMed ID: 38098088
[TBL] [Abstract][Full Text] [Related]
33. Increase in diagnostic yield achieved for 174 whole-exome sequencing cases reanalyzed 1-2 years after initial analysis.
Liu Y; Teng Y; Li Z; Cui J; Liang D; Wu L
Clin Chim Acta; 2021 Dec; 523():163-168. PubMed ID: 34560057
[TBL] [Abstract][Full Text] [Related]
34. Rare Tumor-Normal Matched Whole Exome Sequencing Identifies Novel Genomic Pathogenic Germline and Somatic Aberrations.
Sprissler R; Perkins B; Johnstone L; Babiker HM; Chalasani P; Lau B; Hammer M; Mahadevan D
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32570879
[TBL] [Abstract][Full Text] [Related]
35. Analytical validation of whole exome and whole genome sequencing for clinical applications.
Linderman MD; Brandt T; Edelmann L; Jabado O; Kasai Y; Kornreich R; Mahajan M; Shah H; Kasarskis A; Schadt EE
BMC Med Genomics; 2014 Apr; 7():20. PubMed ID: 24758382
[TBL] [Abstract][Full Text] [Related]
36. CNV analysis using whole exome sequencing identified biallelic CNVs of VPS13B in siblings with intellectual disability.
Enomoto Y; Tsurusaki Y; Yokoi T; Abe-Hatano C; Ida K; Naruto T; Mitsui J; Tsuji S; Morishita S; Kurosawa K
Eur J Med Genet; 2020 Jan; 63(1):103610. PubMed ID: 30602132
[TBL] [Abstract][Full Text] [Related]
37. Genomic alterations in gastric cancers discovered via whole-exome sequencing.
Zhang J; Qiu W; Liu H; Qian C; Liu D; Wang H; Hu N; Tang YT; Sun J; Shen Z
BMC Cancer; 2018 Dec; 18(1):1270. PubMed ID: 30567531
[TBL] [Abstract][Full Text] [Related]
38. Next-Generation Sequencing-Based Detection of Germline Copy Number Variations in BRCA1/BRCA2: Validation of a One-Step Diagnostic Workflow.
Schmidt AY; Hansen TVO; Ahlborn LB; Jønson L; Yde CW; Nielsen FC
J Mol Diagn; 2017 Nov; 19(6):809-816. PubMed ID: 28822785
[TBL] [Abstract][Full Text] [Related]
39. Screening copy number variations in 35 unsolved inherited retinal disease families.
Liu X; Dai H; Li G; Jia R; Meng X; Yu S; Yang L; Hong J
Hum Genet; 2024 Feb; 143(2):197-210. PubMed ID: 38282009
[TBL] [Abstract][Full Text] [Related]
40. Integrated Analysis of Germline and Tumor DNA Identifies New Candidate Genes Involved in Familial Colorectal Cancer.
Díaz-Gay M; Franch-Expósito S; Arnau-Collell C; Park S; Supek F; Muñoz J; Bonjoch L; Gratacós-Mulleras A; Sánchez-Rojas PA; Esteban-Jurado C; Ocaña T; Cuatrecasas M; Vila-Casadesús M; Lozano JJ; Parra G; Laurie S; Beltran S; ; Castells A; Bujanda L; Cubiella J; Balaguer F; Castellví-Bel S
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30871259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
